LUNG CONNECT is an international group of experts in the field of thoracic oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories and Boehringer Ingelheim.
What’s new from LUNG CONNECT
Conference update
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers
Renowned medical experts share their insights into new data presented at ESMO 2024
-
Downloadable
Resources -
MIN
-
Sep 2024
Sep 2024 
Podcast
The HER2 diagnostic and treatment landscape in NSCLC: Episode 1
A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC
Experts
Prof. Fernando López-Ríos, MD, PhD, Dr Devika Das, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
20 MIN
-
Apr 2025
Video
The patient perspective: Living with NSCLC driven by a rare alteration
What to know, what to expect, and where to find support
Experts
Marcia HornEndorsed by
-
8 MIN
-
Apr 2025
HER2 testing: The evolving role of immunohistochemistry (IHC)
Best practices and interpretation of results in lung and ovarian cancer
Experts
Prof. Fernando López-Ríos, MD, PhD, Prof. Christian Rolfo, Prof. Charlie GourleyEndorsed by
-
Downloadable
Resources -
77 MIN
-
Mar 2025
Conference update
Oncogene-addicted NSCLC: Highlights from ELCC 2025
Expert insights on the latest NSCLC data
Experts
Prof. Nicolas GirardEndorsed by
-
Downloadable
Resources -
5 MIN
-
Mar 2025
Podcast
Testing to treatment of BRAF-mutant metastatic NSCLC
Medical experts share their insights on testing and treatment
Experts
Dr Federico CappuzzoEndorsed by
-
Downloadable
Resources -
MIN
-
Nov 2024